亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
meeteryu完成签到,获得积分10
5秒前
Orange应助yao采纳,获得10
12秒前
caspar完成签到,获得积分10
13秒前
李爱国应助科研通管家采纳,获得10
22秒前
ceeray23应助科研通管家采纳,获得10
22秒前
35秒前
小高想去浙大读博完成签到 ,获得积分10
36秒前
yao发布了新的文献求助10
38秒前
49秒前
yao完成签到,获得积分10
50秒前
六六完成签到 ,获得积分10
50秒前
1分钟前
嘻嘻完成签到,获得积分10
1分钟前
1分钟前
1分钟前
jin666发布了新的文献求助10
1分钟前
Criminology34举报朝雨春求助涉嫌违规
2分钟前
研友_VZG7GZ应助lawang采纳,获得10
2分钟前
2分钟前
迷茫的一代完成签到,获得积分10
2分钟前
jin666完成签到,获得积分10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
科研通AI6应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
小蘑菇应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
Criminology34举报清泠求助涉嫌违规
2分钟前
2分钟前
2分钟前
小A同学发布了新的文献求助10
2分钟前
雪白的青柏完成签到,获得积分10
3分钟前
3分钟前
3分钟前
量子星尘发布了新的文献求助10
3分钟前
小A同学完成签到,获得积分10
3分钟前
小蘑菇应助靓丽的魔镜采纳,获得10
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
From Victimization to Aggression 1000
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
Exosomes Pipeline Insight, 2025 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5650979
求助须知:如何正确求助?哪些是违规求助? 4782454
关于积分的说明 15052860
捐赠科研通 4809757
什么是DOI,文献DOI怎么找? 2572566
邀请新用户注册赠送积分活动 1528583
关于科研通互助平台的介绍 1487585